CClinicalTrials.gg
Status unknownNCT04766203Updated Jun 2, 2021

Relative Energy Deficiency in Sport Multicenter Study

An interventional study of Treatment of REDS using a holistic treatment arm in Health, Subjective, Nutrition Disorders and Athletic Injuries, sponsored by Trent Stellingwerff. Status unknown at 1 site in Canada. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-02.

Sponsored by Trent Stellingwerff · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Non-randomized
Ages
15 Years and older
Sex
All
01

Study summary

Relative Energy Deficiency in Sport (RED-S) characterizes a range of negative health and performance outcomes that result from chronically low energy availability. RED-S concerns high performance junior and senior athletes across Canada and has a prevalence rate of 3-60%. Our ability to assess and diagnose RED-S remains poor. Accordingly, we aim to create the best parameters to diagnose and manage RED-S; along with information of the prevalence and severity across Canada and globally. These outcomes are expected to have a significant positive impact on the health and performance of Canadian athletes in preparation for the Olympic Games in 2022 and beyond.

Read the detailed description

Purpose:

Our aim is to improve our understanding of the prevalence and symptoms of RED-S in international and Canadian athletes and para-athletes, along with developing screening tools and treatment protocols to manage RED-S in order to improve athlete health, availability and performance.

Objectives:

  1. Assess the prevalence of self-reported RED-S health outcomes in international and Canadian elite female and male athletes and para-athletes as well as recreational athletes (Study A);
  2. Assess the prevalence and severity of measured standard/basic RED-S health outcomes including biomarkers and potential longitudinal (6-mo) tracking of outcomes across the Canadian Olympic and Paralympic Sport Institute Network (COPSI) (Study B);
  3. Implement a more advanced assessment, using novel RED-S assessment parameters in a smaller cohort of key athletes, including potential longitudinal tracking over a 6-mo period (Study C);
  4. Assess longitudinal changes and the treatment of RED-S symptoms across a 6-month follow-up period in a small cohort of elite Canadian athletes willing to partake in an 'holistic' RED-S treatment intervention arm (Study D);
  5. Utilize the data created from Studies A,B,C,and D to develop and validate potentially novel RED-S assessment parameters in order to further validate the 'new' IOC RED-S clinical assessment tool (CAT) version 2 to aid in the diagnosis of RED-S.

Justification:

This study will be the first to systematically assess the prevalence and severity of outcomes of RED-S in a large group of international and Canadian athletes and para-athletes (A), and within the COPSI network (B,C), utilising physiological and performance tests and training metrics for a more holistic assessment of potential outcomes (B,C,). This study will also aim to strengthen the literature regarding to the time-course of changes in these outcomes (B,C,D) and the efficacy of a simple nutritional intervention arm on these changes (D). Finally, this multicentre project will be the largest to date in Canada and globally, and the first to produce data on the prevalence of RED-S within the COPSI network (across A,B,C,D).

Research Design:

This is an observational study including online survey and physiological testing with potential for follow-up in a subset of athletes. A separate study arm (study D) will be an intervention arm with follow-up.

Statistical analysis:

Analysis will be a combination of basic statistics such as t-tests and ANOVA's, as well as more advanced statistical modelling (e.g. stepwise regression modelling, with first identifying collinearity among independent variables via the implementation of variance inflation factors (VIFs)) as well as questionnaire-based statistics and potentially principal components analysis (PCA) will be implemented.

Physiological data will be plotted against survey data to create links between RED-S symptoms among various athlete groups (female vs male, able bodied vs disabled, sports groups, age categories, etc.)

02

Conditions studied

  • Health, Subjective
  • Nutrition Disorders
  • Athletic Injuries
  • Hormone Disturbance
  • Exercise-related Amenorrhea
  • Eating Disorders
  • Sleep Hygiene
  • Cardiovascular Abnormalities
  • Bone Fracture
  • Bone Loss
  • Weight Change, Body
  • Mental Health Wellness 1
03

In context

Cardiovascular Abnormalities

59 studies on the registry are indexed under Cardiovascular Abnormalities; 14 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 60 across 33 interventional studies indexed under Cardiovascular Abnormalities.

Browse Cardiovascular Abnormalities studies →

Lead sponsor

This is the only study on the registry with Trent Stellingwerff as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • International or Canadian elite (National Sport Organization identified) and (Provincial Sport Organization / University varsity identified) Next Generation, or recreational athlete or para-athlete
  • Female or male athlete or para-athlete currently and actively training for and racing in an Olympic sports event
  • Age >15 years

Exclusion criteria

Exclusion Criteria:

  • Under 15 years old
  • Pregnant
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,000 participants (estimated)

Study arms

  • No intervention
    Global screening of high-performance athletes for REDS

    This arm collects data with an online survey to assess prevalence and signs and symptoms of REDS in elite female and male elite and recreational athletes and para-athletes over the age of 15 years across the world.

  • No intervention
    Basic screening of Canadian high-performance athletes for REDS

    In this study arm, varsity level to elite Canadian athletes and para-athletes will complete a baseline blood sample and potentially (where abnormalities are present) a follow-up 6 months later.

  • No intervention
    Advanced screening of Canadian high-performance athletes for REDS

    In this study arm, varsity level to elite Canadian athletes and para-athletes will complete a baseline test for bone density (DXA scans), resting metabolic rate and exercise testing. Potentially (where abnormalities are present) a follow-up 6 months later.

  • Experimental
    Treatment of Canadian athletes with REDS: a holistic intervention arm

    In this arm, varsity level to elite Canadian athletes and para-athletes with REDS will participate in a nutritional intervention aiming to improve energy availability and thus, REDS status.

    Behavioral: Treatment of REDS using a holistic treatment arm

Interventions

  • BehavioralTreatment of REDS using a holistic treatment arm

    This arm aims to treat athletes with REDS symptoms by implementing a holistic, individualized nutrition intervention to improve energy availability and thus restore impaired body function due to REDS.

06

What researchers measure

Primary outcomes

  1. REDS clinical assessment tool and REDS risk score

    a combination of validated and semi-validated questionnaires

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  2. Menstrual function in females

    via Low Energy Availability in Females Questionnaire (higher scores reflect higher risk of RED-S) and use of urinary ovulation strips to measure LH surge

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  3. Triiodothyronine concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  4. Estrogen concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  5. Testosterone concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  6. Luteinizing hormone concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  7. Follicle-stimulating hormone concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  8. Sex-hormone binding globulin concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  9. Hemoglobin concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  10. Ferritin concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  11. Serum iron concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  12. Total iron binding capacity

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  13. Iron saturation

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  14. Total cholesterol concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  15. LDL cholesterol concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  16. HDL cholesterol concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  17. Triglycerides concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  18. Bone mineral density

    Dual energy x ray scan of lumbar spine and femoral neck bone density

    Time frame: Baseline

  19. Resting metabolic rate

    Assessment done with a metabolic cart by collecting respiratory gases

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  20. Aerobic capacity

    maximal oxygen uptake test

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  21. Strength

    Maximal strength tests

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  22. Insulin like growth factor 1 concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  23. Resting heart rate

    Heart rate monitor (Polar electro)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  24. Blood pressure (systolic and diastolic)

    Blood pressure monitor

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  25. Bone stress injury history

    online questionnaire on type and number of injuries

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

Secondary outcomes

  1. Body composition

    Via DXA or skinfold calipers

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  2. Complete blood count

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  3. Insulin concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  4. Glucose concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  5. Cortisol concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  6. Prolactin concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  7. 25(OH)D concentrations

    Venous blood samples

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  8. illness history

    online questionnaire on frequency of illness in the past 24 months

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  9. Soft-tissue injury history

    online questionnaire on the type and number of injuries in the past 24 months

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  10. Sleep hygiene

    Athlete Sleep Screening Questionnaire (higher scores reflect sleep impairments)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  11. Mental health

    Depression, anxiety and stress scale 21 (higher scores reflect increased mental challenges)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  12. Male athlete health

    Low Energy Availability in Males Questionnaire (scoring is under development but higher scores reflect higher risk of REDS)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  13. Gut health

    Sections from the LEAF-Q (higher scores reflect higher risk of REDS)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  14. Cardiac health

    Questions from the Pre-Participation Examination questionnaire (higher scores reflect higher risk of cardiac symptoms)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  15. Mood state

    Brunel Mood Scales (higher scores reflect higher mood disturbance)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  16. Eating disorder assessment

    Eating Disorder Examination 3 (higher scores reflect higher risk of eating disorders)

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  17. History of weight change

    online questionnaire

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  18. History of anemia

    online questionnaire

    Time frame: Baseline and possibly change after 6 months for a subset of athletes

  19. REDS treatment arm

    holistic nutrition based treatment of REDS symptoms including increasing energy availability via nutrition counselling

    Time frame: Individualised but likely 3-6 months

07

Study locations

1 of 1 sites recruiting
  • University of Victoria
    Victoria, British Columbia V8W 2Y2, Canada
    • Trent Stellingwerff, Ph.D. · Contact · tstellingwerff@csipacific.ca · 250-220-6674
    • Ida A Heikura, Ph.D. · Contact · iheikura@csipacific.ca · 778-587-8508
    • Trent Stellingwerff, Ph.D. · Principal investigator
    • Ida A Heikura, Ph.D. · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — No data will be shared with researchers outside of the study team.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04766203
Lead sponsor
Trent Stellingwerff
Collaborators
Mitacs, University of British Columbia
Responsible party
Trent Stellingwerff (Director of Performance Solutions, Innovation & Research for Canadian Sport Institute Pacific (CSI Pacific) Adjunct Faculty - Exercise Science, Physical & Health Education (EPHE), University of Victoria (UVic), University of Victoria) — Sponsor-investigator
First posted
Feb 23, 2021
Start date
May 5, 2021
Primary completion
Jul 31, 2022 (estimated)
Completion
Jul 31, 2022 (estimated)
Last update
Jun 2, 2021

Study contacts

Trent Stellingwerff, Ph.D.
Contact
tstellingwerff@csipacific.ca
250-208-6674
Ida A Heikura, Ph.D.
Contact
iheikura@csipacific.ca
778-587-8508
Trent Stellingwerff, Ph.D.
principal investigator · Canadian Sport Institute Pacific, University of Victoria, University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion